27561345|t|Teriparatide: benefit and safety for bone disease in CKD patients undergoing hemodialysis
27561345|a|Teriparatide, 1-34 parathyroid hormone, is one of effective treatments for osteoporosis. Teriparatide shows an anabolic effect for bone formation, as a result, increases bone mineral density as well as prevention of fractures in the general population. On the other hand, there are a few report about the effect of teriparatide on increase of bone mineral density in maintenance hemodialysis patients. In addition to CKD-MBD, osteoporosis is also an important pathological change in ESRD patients, therefore its safety and efficacy should be discussed in more detail.
27561345	0	12	Teriparatide	T103	UMLS:C0070093
27561345	37	49	bone disease	T038	UMLS:C0005940
27561345	53	56	CKD	T038	UMLS:C1561643
27561345	77	89	hemodialysis	T058	UMLS:C0019004
27561345	90	102	Teriparatide	T103	UMLS:C0070093
27561345	104	128	1-34 parathyroid hormone	T103	UMLS:C1956225
27561345	150	160	treatments	T058	UMLS:C0087111
27561345	165	177	osteoporosis	T038	UMLS:C0029456
27561345	179	191	Teriparatide	T103	UMLS:C0070093
27561345	201	216	anabolic effect	T038	UMLS:C3179309
27561345	221	235	bone formation	T038	UMLS:C0029433
27561345	260	280	bone mineral density	T201	UMLS:C0005938
27561345	306	315	fractures	T037	UMLS:C0016658
27561345	331	341	population	T098	UMLS:C1257890
27561345	405	417	teriparatide	T103	UMLS:C0070093
27561345	433	453	bone mineral density	T201	UMLS:C0005938
27561345	469	481	hemodialysis	T058	UMLS:C0019004
27561345	507	514	CKD-MBD	T038	UMLS:C4076240
27561345	516	528	osteoporosis	T038	UMLS:C0029456
27561345	550	562	pathological	T091	UMLS:C0030664
27561345	573	577	ESRD	T038	UMLS:C0022661
27561345	602	608	safety	T062	UMLS:C1705187
27561345	613	621	efficacy	T062	UMLS:C1707887